WebBirgit Girshick , Corporate Executive Vice President, Discovery & Safety Assessment, Biologics Testing Solutions, and Avian Vaccine Services at Charles River ... Source: Charles River Laboratories International, Inc. Investor Contact: Todd Spencer Corporate Vice President, Investor Relations 781-222-6455 [email protected] WebNov 11, 2024 · WILMINGTON, Mass.-- ( BUSINESS WIRE )--Charles River Laboratories International, Inc. (NYSE:CRL) today announced that Birgit Girshick has been …
New York State Teachers Retirement System Reduces Position in Charles …
WebMar 8, 2024 · The estimated Net Worth of Birgit Girshick is at least $15.9 Million dollars as of 16 February 2024. Ms. Girshick owns over 3,205 units of Charles River Laboratories International stock worth over $8,660,125 … Web– Birgit Girshick, Corporate Executive Vice President, Discovery and Safety Assessment, Biologics Testing Solutions, and Avian Vaccine Services, Charles River “Charles River is the premier CRO in discovery and early development services, and we are thrilled to partner with their team to drive a combined offering. Our Falcon-X™ platform ... retreat hotel
Charles River Announces Strategic Partnership with Cypre, …
WebNov 11, 2024 · Birgit Girshick joined Charles River in 1989 and held positions of increasing responsibility in the Company’s Research Models and Services (RMS) Germany and Avian Vaccine Services businesses. In 2010, Ms. Girshick was promoted to Corporate Vice President, Biologics Testing Solutions, followed by a promotion to Corporate Senior … WebBirgit Girshick is Exec VP/COO at Charles River Laboratories Inc. See Birgit Girshick's compensation, career history, education, & memberships. WebApr 9, 2024 · Insider Buying and Selling at Charles River Laboratories International. In other news, COO Birgit Girshick sold 3,205 shares of the firm’s stock in a transaction dated Thursday, February 16th. The stock was sold at an average price of $254.39, for a total transaction of $815,319.95. retreat hospital jobs